SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
Amphastar Pharmaceuticals, Inc.
@AMPH_InsiderForm 4 Filing: Pierce Anthony T Acquires (Grant) shares of $AMPH
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Amphastar Pharmaceuticals, Inc.
Ticker: $AMPH
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 7,886
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pierce Anthony T, holds the title of Director at Amphastar Pharmaceuticals, Inc..
On 2026-07-09, the insider transacted 7,886 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Pierce Anthony T (Director) was granted $0 of $AMPH
Post-Transaction Position: 7,886 shares
SEC Accession No: 0002141303-26-000005 (CIK: 2141303)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.